INNO.CN
Innocan Pharma Corp
Price:  
0.21 
CAD
Volume:  
6,020.00
Israel | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INNO.CN WACC - Weighted Average Cost of Capital

The WACC of Innocan Pharma Corp (INNO.CN) is 6.7%.

The Cost of Equity of Innocan Pharma Corp (INNO.CN) is 6.70%.
The Cost of Debt of Innocan Pharma Corp (INNO.CN) is 5.00%.

Range Selected
Cost of equity 5.40% - 8.00% 6.70%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 8.0% 6.7%
WACC

INNO.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.44 0.63
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 8.00%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 8.0%
Selected WACC 6.7%